Head, Neck and Thyroid Cancers | Key Abstracts in Head, Neck and Thyroid Cancers from the 2022 ASCO Annual Meeting

Research To Practice | Oncology Videos

Контент предоставлен Dr Neil Love. Весь контент подкастов, включая выпуски, графику и описания подкастов, загружается и предоставляется непосредственно Dr Neil Love или его партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.

1+ y ago 49:48

MP4•Главная эпизода

Featuring an interview with Dr Ezra Cohen, including the following topics:

Spectrum of targetable mutations in thyroid cancer and impact on treatment selection (0:00)
Comparative efficacy of TRK inhibitors in patients with thyroid cancer, including those with CNS disease (6:06)
Current and emerging roles of immunotherapy alone and in combination with tyrosine kinase inhibitors for patients with head and neck cancer (10:17)
Predicting clinical response to immunotherapy for patients with head and neck cancers (19:47)
Role of dose reduction in managing toxicities associated with immunotherapy and targeted agents (26:01)
Current and potential roles for cell-free DNA testing and minimal residual disease assessment in the management of head and neck cancer (32:08)
Recently reported efficacy data with avasopasem in the treatment of radiation-induced oral mucositis (35:27)
Factors affecting response to immunotherapy (42:07)

CME information and select publications

1360 эпизодов

#Science #Medicine #Cancer #Neillove #Oncology #Researchtopractice #Fitness #Dr Neil Love #Video